March 6, 2023 — The American Roentgen Ray Society (ARRS) proudly recognizes the following four radiologists, as well as their research, with the 2023 ARRS Resident/Fellow in Radiology Awards: 

  

Elliot T. Varney, MD | University of Mississippi Medical Center 

ARRS Resident/Fellow in Radiology Melissa Rosado de Christenson Award 

March 3, 2023 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging

March 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, announced the installation of its RefleXion X1 platform at Smilow Cancer Hospital, part of

March 2, 2023 —  GE HealthCare announced at the European Congress of Radiology (ECR) in Vienna, Austria, the completion of Phase I subject recruitment in its early clin

March 2, 2023 —Royal Philips announced new milestones in the development of the world’s first spectral detector angio CT solution - 

March 2, 2023 — Carestream Health is funding and participating in an innovative pilot with the Open Source Imaging Consortium (OSIC) that could lead to radiographs providing an early window into manifestat

March 3, 2023 — Oxipit, a creator of AI tools for global medical imaging, has announced that its diagnostic AI solutions will be available on the CARPL platform. CARPL platform users will have access to the full Oxipit AI product portfolio: ChestLink for healthy patient report automation, Quality for real-time quality assurance and ChestEye for preliminary reports.

March 2, 2023 — Qure.ai, a London-based medical Artificial Intelligence (AI) imaging company, has announced a new partnership with Therapixel, a French firm that uses AI to improve the early breast cancer detection, whereby Qure.ai will be a global distributor for Therapixel’s MammoScreen.

March 2, 2023 —  Ascelia Pharma, a biotech company focused on improving the life of people living with rare cancer conditions, has announced the successful completion of patient enrollment in its pivotal phase 3 clinical study,

Subscribe Now